Literature DB >> 3535928

Interleukin-1 (22-K factor) induces release of granulocyte-macrophage colony-stimulating activity from human mononuclear phagocytes.

W E Fibbe, J van Damme, A Billiau, P J Voogt, N Duinkerken, P M Kluck, J H Falkenburg.   

Abstract

An electrophoretically pure preparation of natural human interleukin-1 (IL-1) was shown to stimulate in vitro colony formation in human bone marrow cultures. Day 4 myeloid cluster-forming cells (CFC), as well as early (day 7) and late (day 10) granulocyte-macrophage colony-forming units (CFU-GM) were stimulated in a dose-dependent fashion. At optimal concentrations of IL-1, the number of day 4 CFC reached 72%, the number of day 7 CFU-GM reached 32%, and the number of day 10 CFU-GM reached 80% of the respective numbers of colonies obtained by addition of crude leukocyte-conditioned medium (LCM). The IL-1-induced stimulatory effect on CFU-GM growth could be completely neutralized by a rabbit anti-IL-1 antiserum. Colony growth was abrogated by depleting the marrow cell suspensions of phagocytic cells prior to IL-1 addition. Conversely, the effect could be reintroduced by addition of marrow-derived adherent cells to bone marrow cell suspensions that had been depleted of both phagocytic and E rosetting T cells. Furthermore, media conditioned by bone marrow-derived adherent cells or by peripheral blood mononuclear phagocytes in the presence but not in the absence of IL-1, stimulated in vitro colony growth of phagocyte-depleted bone marrow cell suspensions. These results indicate that IL-1 induces release of granulocyte-macrophage colony-stimulating activity (GM-CSA) from human mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3535928

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro.

Authors:  J Brandt; N Baird; L Lu; E Srour; R Hoffman
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

Review 2.  Interleukin-4. A regulatory protein.

Authors:  J H Jansen; W E Fibbe; R Willemze; J C Kluin-Nelemans
Journal:  Blut       Date:  1990-05

Review 3.  Interaction of interferon with other cytokines.

Authors:  G Opdenakker; Y Cabeza-Arvelaiz; J Van Damme
Journal:  Experientia       Date:  1989-06-15

4.  The effect of natural and surgical menopause on the secretion of cytokines from human blood monocytes.

Authors:  R Pacifici; L V Avioli
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

5.  Regulation of human monocyte adherence by granulocyte-macrophage colony-stimulating factor.

Authors:  J R Gamble; M J Elliott; E Jaipargas; A F Lopez; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Combination effect of recombinant human interleukin-1 alpha with antimicrobial agents.

Authors:  S Nakamura; A Minami; K Fujimoto; T Kojima
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

7.  Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages.

Authors:  M A Smith; S M Knight; P J Maddison; J G Smith
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

8.  Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type.

Authors:  G C Bagby; C A Dinarello; R C Neerhout; D Ridgway; E McCall
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

9.  Effects of colony-stimulating factors on proliferation and activation of synovial cells.

Authors:  M Yamamoto; M Yasuda; S Shiokawa; M Nobunaga
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

10.  No effect of recombinant human interleukin-1 on numbers of peripheral blood and peritoneal leukocytes during acute inflammation.

Authors:  B J Kullberg; J W Van't Wout; R van Furth
Journal:  Inflammation       Date:  1991-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.